Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • sun pharma

    Tag: sun pharma

    You Searched For "sun-pharma"
    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Medical Dialogues Bureau30 March 2020 7:48 AM GMT
    Mumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each

    Medical Dialogues Bureau17 March 2020 11:48 AM GMT
    New Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a...
    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Medical Dialogues Bureau3 March 2020 7:06 AM GMT
    The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to...
    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Farhat Nasim6 Jan 2020 7:45 AM GMT
    New Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 10:59 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee

    Farhat Nasim10 Nov 2019 12:07 PM GMT
    New Delhi: In a major setback to the country's largest drugmaker Sun Pharmaceuticals Ltd. (Sun Pharma), the firm has been accused of allegedly...
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Medical Dialogues Bureau6 Nov 2019 7:56 AM GMT
    Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Medical Dialogues Bureau5 Nov 2019 7:25 AM GMT
    New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 7:43 AM GMT
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Farhat Nasim11 Oct 2019 4:00 AM GMT
    New Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    Farhat Nasim5 Oct 2019 6:30 AM GMT
    Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X